PANTOPRAZOLO HIKMA Italia - italia - AIFA (Agenzia Italiana del Farmaco)

pantoprazolo hikma

hikma farmaceutica (portugal) s.a. - pantoprazolo - pantoprazolo

Sorafenib Accord Euroopan unioni - italia - EMA (European Medicines Agency)

sorafenib accord

accord healthcare s.l.u. - sorafenib tosilate - carcinoma, hepatocellular; carcinoma, renal cell - agenti antineoplastici - hepatocellular carcinomasorafenib accord is indicated for the treatment of hepatocellular carcinoma (see section 5. renal cell carcinomasorafenib accord is indicated for the treatment of patients with advanced renal cell carcinoma who have failed prior interferon-alpha or interleukin-2 based therapy or are considered unsuitable for such therapy.

TAIGALOR Italia - italia - AIFA (Agenzia Italiana del Farmaco)

taigalor

takeda italia s.p.a. - oxicam-derivati - oxicam-derivati

XEFO Italia - italia - AIFA (Agenzia Italiana del Farmaco)

xefo

takeda italia s.p.a. - lornoxicam - lornoxicam

PANCLEUS Italia - italia - AIFA (Agenzia Italiana del Farmaco)

pancleus

s.f. group s.r.l. - pantoprazolo - pantoprazolo

PANTOPRAZOLO PENSA Italia - italia - AIFA (Agenzia Italiana del Farmaco)

pantoprazolo pensa

towa pharmaceutical s.p.a. - pantoprazolo - pantoprazolo